Related Experiment Video

Updated: Dec 27, 2025

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

534

Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not

Dae Won Jun1, Mindie H Nguyen2

  • 1Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

Alimentary Pharmacology & Therapeutics
|February 27, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.5K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.5K

Related Concept Videos